ÂÜÀòÂÒÂ×

Raymond Ng is a seasoned professional in the field of drug discovery and development, currently serving as Sr. Director at Olema Oncology since November 2021. Previously, Raymond held the position of Associate Director at Shanghai ChemPartner from October 2016 to November 2021, leading multiple neurodegeneration and oncology drug discovery projects in collaboration with academic partners and startups. Prior experience includes Sr. Principal Scientist roles at CoMentis, where management of overseas CROs and CMC activities was pivotal, and site safety officer at Elan Pharmaceuticals, among other key positions at Atherogenics and Johnson and Johnson. Raymond Ng holds a PhD in Organic Chemistry from the University of Wisconsin-Madison and a BS in Biochemistry from Indiana University Bloomington.